200 related articles for article (PubMed ID: 17180527)
1. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide.
Higuchi A; Ogata N; Jo N; Wada M; Matsumura M
Jpn J Ophthalmol; 2006; 50(6):529-531. PubMed ID: 17180527
[TBL] [Abstract][Full Text] [Related]
2. Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
Koga T; Mawatari Y; Inumaru J; Fukushima M; Tanihara H
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1247-52. PubMed ID: 16021497
[TBL] [Abstract][Full Text] [Related]
3. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane.
Matsumoto H; Yamanaka I; Hisatomi T; Enaida H; Ueno A; Hata Y; Sakamoto T; Ogino N; Ishibashi T
Retina; 2007 Feb; 27(2):174-9. PubMed ID: 17290199
[TBL] [Abstract][Full Text] [Related]
4. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema.
Parolini B; Panozzo G; Gusson E; Pinackatt S; Bertoldo G; Rottini S; Pignatto S
Semin Ophthalmol; 2004; 19(1-2):1-12. PubMed ID: 15658006
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sub-Tenon's capsule injection of triamcinolone acetonide for refractory diabetic macular edema after vitrectomy.
Sato H; Naito T; Matsushita S; Takebayashi M; Shiota H
J Med Invest; 2008 Aug; 55(3-4):279-82. PubMed ID: 18797143
[TBL] [Abstract][Full Text] [Related]
7. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy.
Shimonagano Y; Doi N; Noda Y; Uemura A; Sakamoto T
Jpn J Ophthalmol; 2007; 51(4):278-84. PubMed ID: 17660988
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
12. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Batioğlu F; Ozmert E; Parmak N; Celik S
Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
Watanabe A; Tsuzuki A; Arai K; Gekka T; Kohzaki K; Tsuneoka H
J Ocul Pharmacol Ther; 2016; 32(1):38-43. PubMed ID: 26325253
[TBL] [Abstract][Full Text] [Related]
15. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.
Pendergast SD; Hassan TS; Williams GA; Cox MS; Margherio RR; Ferrone PJ; Garretson BR; Trese MT
Am J Ophthalmol; 2000 Aug; 130(2):178-86. PubMed ID: 11004291
[TBL] [Abstract][Full Text] [Related]
16. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
Rosenblatt BJ; Shah GK; Sharma S; Bakal J
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):20-5. PubMed ID: 15290152
[TBL] [Abstract][Full Text] [Related]
19. Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy.
Doi N; Uemura A; Nakao K; Sakamoto T
Retina; 2005 Sep; 25(6):742-5. PubMed ID: 16141862
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Jonas JB; Söfker A; Degenring R
Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
